Financing for the transaction, whose amount was not disclosed, was provided by Madison Capital.
The Marena Group manufactures medical-grade compression garments, shapewear, and activewear sold to plastic surgery centers, hospitals, medical providers, patients, and consumers. Its compression garments are used by plastic surgery patients for post-surgical applications, and by consumers for shapewear to enhance comfort, support, and appearance.
The company’s customer base includes thousands of medical providers and individual consumers in the U.S., as well as over 50 international distributors selling into nearly 80 countries.
Marena’s existing management team will continue leading the company and CEO Vera Watkins will remain in place. Riverside intends to work with the existing management to expand Marena through increased sales and marketing, international growth, widening its customer base, new product development, and entering new markets.